SCHEMBL5488868

SCHEMBL5488868

Oc1cc[c]cc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1927256 0.79
SCHEMBL127281 0.75
SCHEMBL694289 0.70
SCHEMBL702714 0.68
SCHEMBL5095094 0.68
SCHEMBL690348 0.68
SCHEMBL3395205 0.68
SCHEMBL183542 0.68
SCHEMBL75115 0.68
SCHEMBL4032027 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101914080-B Benzofuran-3-ketone substitute phenyl compound as well as preparation method and application UNIV SHANGHAI JIAOTONG 2012-10-03 CN claimed
CN-101914080-A Benzofuran-3-ketone substitute phenyl compound as well as preparation method and application UNIV SHANGHAI JIAOTONG 2010-12-15 CN claimed
EP-2948188-B1 NEURONAL IMAGING AND TREATMENT TYLERTON INT HOLDINGS INC (VG) 2021-09-08 EP disclosed
CN-110272400-A The synthetic method of 2- trifluoromethyl substituted furan compound and its derivative 福州大学 2019-09-24 CN disclosed
CN-104994885-B Method and composition for radiohalogen protein labeling 基因泰克公司 2017-09-29 CN disclosed
US-9486546-B2 Methods and compositions for radiohalogen protein labeling GENENTECH, INC. (US) 2016-11-08 US disclosed
US-9393327-B2 Methods and compositions for radiohalogen protein labeling GENENTECH, INC. (US) 2016-07-19 US disclosed
US-20160002121-A1 METHODS AND COMPOSITIONS FOR RADIOHALOGEN PROTEIN LABELING GENENTECH, INC. (US) 2016-01-07 US disclosed
US-20150366523-A1 NEURONAL IMAGING AND TREATMENT TYLERTON INTERNATIONAL HOLDINGS INC. (VG) 2015-12-24 US disclosed
EP-2948188-A1 NEURONAL IMAGING AND TREATMENT Tylerton International Holdings Inc. (VG) 2015-12-02 EP disclosed
EP-2934602-A1 METHODS AND COMPOSITIONS FOR RADIOHALOGEN PROTEIN LABELING Genentech, Inc. (US) 2015-10-28 EP disclosed
EP-0885017-A2 USE OF LABELLED CCK-B RECEPTOR LIGANDS FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMOURS MALLINCKRODT MEDICAL, INC. (US) 1998-12-23 EP disclosed
WO-1998033531-A1 METHOD FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMOURS MALLINCKRODT MEDICAL, INC. (US) 1998-08-06 WO disclosed
WO-1997031657-A2 USE OF LABELLED CCK-B RECEPTOR LIGANDS FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMORS MALLINCKRODT MEDICAL, INC. (US) 1997-09-04 WO disclosed
WO-1996023527-A9 METHOD FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMOURS 1996-10-03 WO disclosed
WO-1996023527-A1 METHOD FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMOURS MALLINCKRODT MEDICAL, INC. (US) 1996-08-08 WO disclosed
EP-0595743-A1 Bihaptinic derivatives for binding for technetium or rhenium, process for their preparation, application for diagnosis and therapy, kits and immunological reactants comprising them IMMUNOTECH PARTNERS:Société Anonyme dite (FR) 1994-05-04 EP disclosed
US-5242680-A Diagnostic and therapeutic MERCK & CO., INC. (US) 1993-09-07 US disclosed
EP-0524722-A1 Thiol-reactive maleimido-based radiolabeling reagents MERCK & CO. INC. (US) 1993-01-27 EP disclosed
US-4197309-A AND THEIR OXIMES, USED TO INDUCE URICOSIC EFFECT WITHOUT DIURESIS ALBERT ROLAND S.A. (FR) 1980-04-08 US disclosed